Masimo (MASI) EBIT Growth (1y) (2010 - 2026)
Masimo (MASI) EBIT Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -20.56% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 11.83% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 30.43% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 19.54% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 20.97% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 90.95% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 74.18% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -18.12% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Masimo | 9.39 Bn | 9.27 Bn | 250.80 Mn | -0.77% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | -0.77% |
| Jan 3, 2026 | 219.35% |
| Sep 27, 2025 | 118.85% |
| Jun 28, 2025 | 53.94% |
| Mar 29, 2025 | 46.89% |
| Dec 28, 2024 | -195.65% |
| Sep 28, 2024 | 51.59% |
| Jun 29, 2024 | 43.00% |
| Mar 30, 2024 | 39.74% |
| Dec 30, 2023 | -51.39% |
| Sep 30, 2023 | -54.01% |
| Jul 1, 2023 | 32.58% |
| Apr 1, 2023 | -36.35% |
| Dec 31, 2022 | 95.32% |
| Oct 1, 2022 | -18.93% |
| Jul 2, 2022 | -66.05% |
| Apr 2, 2022 | -9.08% |
| Jan 1, 2022 | 19.29% |
| Oct 2, 2021 | 13.24% |
| Jul 3, 2021 | 4.63% |